CNS: SEIZURES, anxiety, dizziness, headache, irritability
EENT: blurred vision, tinnitus
CV: CARDIOVASCULAR COLLAPSE, arrhythmias, bradycardia, hypotension
GI: nausea, vomiting
GU: urinary retention
F and E: metabolic acidosis
Neuro: circumoral tingling/numbness, tremor
Misc: allergic reactions, fever
Assess for systemic toxicity (circumoral tingling and numbness, ringing in ears, metallic taste, dizziness, blurred vision, tremors, slow speech, irritability, twitching, seizures, cardiac dysrhythmias). Report to physician or other health care professional.
Monitor BP, HR, and respiratory rate continuously while patient is receiving this medication.
Monitor for return of sensation after procedure.
Hypersensitivity. Contraindicated before 20 weeks of gestation and if continuing the pregnancy is hazardous to the mother or fetus, as in fetal distress, premature rupture of membranes, hemorrhage, chorioamnionitis, and intrauterine fetal death. Contraindicated in conditions that may be adversely affected by beta-adrenergic agents (uncontrolled diabetes, hyperthyroidism, bronchial asthma treated with other beta-adrenergic agents or steroids, cardiac dysrhythmias, hypovolemia, uncontrolled hypertension). • 1. Cardiovascular: Maternal and fetal tachycardia, palpitations, cardiac dysrhythmias, chest pain, wide pulse pressure
• 2. Respiratory: Dyspnea, chest discomfort
• 3. Central nervous system: Tremors, restlessness, weakness, dizziness, headache
• 4. Metabolic: Hypokalemia, hyperglycemia
• 5. Gastrointestinal: Nausea, vomiting, reduced bowel motility
• 6. Skin: Flushing, diaphoresis
Diagnostic studies that may be ordered related to terbutaline therapy: electrocardiogram, levels of blood glucose and electrolytes, urinalysis. Explain common side effects such as palpitations, tremors, restlessness, weakness, headache. Assess fetal heart rate (FHR), usually with continuous electronic fetal monitoring when the drug is initiated, recording rate and patterns at recommended intervals and with IV dose increases. Assess maternal pulse rate, respirations, and blood pressure by same schedule as for FHR. Maintain adequate IV or oral hydration. Encourage the woman to empty her bladder every 2 hours. Notify the physician for significant or unacceptable side effects (maternal heart rate >120 bpm, respirations >24/min, dyspnea, pulmonary edema, systolic blood pressure <80 to 90 mm Hg, FHR >160 bpm, chest pain). Report continuing or recurrent uterine activity. Teach signs and symptoms of recurrent preterm labor and follow-up medical care after discharge.